← Leaderboards
Shaharyar Khan
Gencia Corporation
$196,192
Attributed
$196,192
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$196,192 · 1
By mechanism
N43$196,192 · 1
Top collaborators
No co-investigators on record.
Most similar at Gencia Corporation
Same institution · by research overlap
- Rafal M Smigrodzki$1,294,657
Others in their field
Top investigators on “Adenocarcinoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$39,462,948
- Anirban Maitra · Johns Hopkins University$30,605,004
- Richard M Peek · Vanderbilt University Medical Center$23,246,493
- Gloria M. Petersen · Johns Hopkins University$21,134,227
- Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr$19,098,764
- Dean E. Brenner · University Of Michigan At Ann Arbor$18,393,816
Research focus
AdenocarcinomaAdenocarcinoma CellApoptosisApoptoticBioenergeticsCell LineCell ProliferationCollectionComplexDoseFunctional DisorderGlucose OutputGlycolysisIndexingMalignant Breast NeoplasmMcf7 CellMembrane PotentialsMitochondriaMitochondrial DnaMitochondrial MembraneMttf1 Transcription FactorMutateNeoplasm MetastasisNeoplasms